Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM1 Ganglioside in Parkinson's Disease
NCT00037830Phase 2Completed
- Sponsor
- Thomas Jefferson University
- Start
- Nov 1999
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of monosialotetrahexosylganglioside in Parkinson's disease (PD), sponsored by Thomas Jefferson University. Started Nov 1999; status: completed.
02
Drugs
monosialotetrahexosylganglioside
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00037830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00037830.